A biotech news article about a newly accepted patent application describing a proposed CBD-plus-fibroblast approach for treating degenerative spinal discs, inviting readers to learn how the company frames this combined therapy and its potential pathway.
Key Takeaways
- Announced the acceptance by IP Australia of Australian Patent Application No
- Degenerative disc disease is one of the most common causes of chronic back and neck pain
- Current treatment options are largely limited to pain management